SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Cell>Point Presents Phase 2 Clinical Trial Results Comparing its 99mTc-EC-G SPECT Cancer Imaging Agent to FDG PET at Society of Nuclear Medicine Annual Meeting June 7, 2011